This inventor holds 2 USPTO granted patents. Top assignee: Fudan University. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: **Innovative Contributions of Inventor Wang Liang**
Introduction
Wang Liang is a notable inventor based in Shanghai, China, with a remarkable focus on advancements in biotechnology. With two patents to his name, his work has the potential to significantly influence the field of coagulation treatment.
Latest Patents
Wang Liang's latest patents include innovative solutions in the domain of genetically modified tissue factor pathway inhibitors (TFPI). His first patent outlines long half-life genetically modified TFPI sequences designed for anticoagulation. This invention specifically incorporates modifications where lysine at the carboxy-terminal sites 241, 254, 260, and 261 are substituted with alanine. Furthermore, it notes that asparagine replaces the amino acids at glycosylation sites 117, 167, and 228, while serine and threonine are substituted at sites 174 and 175. Additionally, he provides methods for producing these modified sequences through a high-efficiency LTFPI expression system using yeast.
His second patent also involves the creation of long half-life genetically modified TFPI sequences, further emphasizing the significance and applicability of his research methods in anticoagulation therapies.
Career Highlights
Wang Liang is affiliated with Fudan University, where he conducts his groundbreaking research and development. His diligent work in the field has led him to achieve notable milestones, contributing to the ongoing advancement of medical biotechnology. His dual patent achievements underscore his prowess and dedication as an inventor, positioning him as a leader in his field.
Collaborations
Throughout his career, Wang Liang has collaborated with esteemed colleagues, including Duan Ma and Jingui Mu. Together, they pursue innovative solutions to complex biological challenges, enhancing the potential impact of their collective research.
Conclusion
Wang Liang stands out as an influential inventor in the realm of biotechnology, specializing in innovative anticoagulation treatments. His patented work on genetically modified TFPI not only showcases his technical expertise but also promises to advance medical treatment options significantly. As his career evolves, the contributions of Wang Liang are sure to inspire future research and innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile